Cisco Systems Inc vs Cassava Sciences Inc — how do they compare? Cisco Systems Inc trades at $121.05 (market cap $483.10B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Cisco Systems Inc is far larger — about 10117.3× Cassava Sciences Inc's market cap, and Cisco Systems Inc pays a 1.37% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| CSCO | FLNA | |
|---|---|---|
Market Cap | $483.10B | $47.75M |
Volume | 22,887,319 | — |
Sector | Technology | Health |
52-Week High | $130.00 | $4.64 |
52-Week Low | $66.20 | $0.87 |
Enterprise Value | $497.76B | -$34.93M |
Dividend Yield | 1.37% | — |
Signals from Pluang's Aura AI — not financial advice
Cisco Systems (CSCO) trades at $120.43, down 0.82% on the day, amid a bullish technical outlook and strong earnings beats. The stock shows robust fundamentals with a 64.33% gross margin and consistent quarterly EPS outperformance. Recent AI cybersecurity initiatives and partner expansions fuel positive sentiment, with a consensus price target of $133.25 implying upside potential.
The outlook remains favorable given AI-driven growth catalysts and solid cash flow, though elevated valuation ratios and competitive pressures pose risks. Analyst consensus leans bullish with 52% buy ratings, supporting a constructive view for investors seeking exposure to networking and cybersecurity trends.
FLNA trades at $0.995, up 3.75% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of -$0.18 beating expectations of -$0.225. Financials show negative cash flows and profitability, with ROE at -55.79% and net income of -$90.97M in 2025. Analyst consensus is strongly positive with 8 buy ratings out of 12.
Despite operational losses, FLNA's consistent earnings beats and strong analyst support suggest potential upside if clinical developments progress. Key risks include sustained cash burn, lack of revenue, and dependence on successful drug trials for Tuberous Sclerosis Complex. The stock remains speculative with high volatility expected.
Trailing returns across standard periods
Latest headlines on both assets
Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.
Read more on CSCO →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →